While the obesity-related increase in circulating FFA promotes the development of hepatic steatosis and insulin resistance, the precise molecular mechanisms involved in the interplay among FFA, TLR4 and NOX2 have not been fully understood. The gene discussed is CYBB; the disease is fatty liver disease.